全文获取类型
收费全文 | 8331篇 |
免费 | 622篇 |
国内免费 | 378篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 77篇 |
妇产科学 | 21篇 |
基础医学 | 334篇 |
口腔科学 | 41篇 |
临床医学 | 917篇 |
内科学 | 3963篇 |
皮肤病学 | 24篇 |
神经病学 | 265篇 |
特种医学 | 816篇 |
外国民族医学 | 1篇 |
外科学 | 933篇 |
综合类 | 1133篇 |
预防医学 | 142篇 |
眼科学 | 76篇 |
药学 | 273篇 |
7篇 | |
中国医学 | 42篇 |
肿瘤学 | 198篇 |
出版年
2024年 | 8篇 |
2023年 | 149篇 |
2022年 | 261篇 |
2021年 | 408篇 |
2020年 | 361篇 |
2019年 | 304篇 |
2018年 | 371篇 |
2017年 | 273篇 |
2016年 | 333篇 |
2015年 | 364篇 |
2014年 | 652篇 |
2013年 | 635篇 |
2012年 | 453篇 |
2011年 | 515篇 |
2010年 | 438篇 |
2009年 | 466篇 |
2008年 | 429篇 |
2007年 | 499篇 |
2006年 | 389篇 |
2005年 | 325篇 |
2004年 | 288篇 |
2003年 | 233篇 |
2002年 | 234篇 |
2001年 | 163篇 |
2000年 | 123篇 |
1999年 | 100篇 |
1998年 | 122篇 |
1997年 | 122篇 |
1996年 | 90篇 |
1995年 | 61篇 |
1994年 | 51篇 |
1993年 | 19篇 |
1992年 | 20篇 |
1991年 | 19篇 |
1990年 | 9篇 |
1989年 | 6篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 6篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有9331条查询结果,搜索用时 31 毫秒
1.
2.
《Archives of Cardiovascular Diseases》2022,115(10):505-513
Central illustration: cumulative major adverse cardiac events (MACE) and bioresorbable vascular scaffold (BVS) thrombosis rates after 1, 2, 3, 4 and 5 years. 相似文献
3.
4.
《Clínica e investigación en ginecología y obstetricia》2022,49(2):100721
Intravascular papillary endothelial hyperplasia or Masson's tumour is a non-neoplastic vascular lesion of reactive character. It is a rare diagnosis, clinically non-specific and with diverse locations. It is essential to take it into consideration and make a differential diagnosis with malignant vascular tumours such as angiosarcoma. Pathological study is fundamental for diagnosis. Treatment consists of complete resection of the tumour, including sufficiently wide margins to avoid recurrence.The case reported is an exceptional event, because of the pelvic location of the Masson's tumour that was diagnosed as part of the surgical staging of an ovarian cancer. 相似文献
5.
《Journal of Cardiovascular Computed Tomography》2019,13(5):254-260
Invasive coronary plaque imaging such as intravascular ultrasound and optical coherence tomography has been widely used to observe culprit or non-culprit coronary atherosclerosis, as well as optimize stent sizing, apposition and deployment. Coronary computed tomographic angiography (CTA) is non-invasively available to assess coronary artery disease (CAD) and has become an appropriate strategy to evaluate patients with suspected CAD. Given recent technologies, semi-automated plaque software is available to identify coronary plaque stenosis, volume and characteristics and potentially allows to be used for the assessment of more details of plaque information, progression and future risk as a surrogate tool of the invasive imaging modalities. This review article aims to focus on various evidence in coronary plaque imaging by coronary CTA and describes how accurate coronary CTA can classify coronary atherosclerosis. 相似文献
6.
7.
《Journal of vascular and interventional radiology : JVIR》2020,31(4):630-634
PurposeTo retrospectively evaluate the safety and effectiveness of the Covera stent graft (SG) for the treatment of dysfunctional or thrombosed arteriovenous grafts (AVGs).Materials and MethodsWithin 29 months (February 2016–August 2018), 79 patients underwent Covera SG placement in the authors’ department for the treatment of dysfunctional AVGs. Data were available for 64 patients who underwent 64 procedures, using 64 devices. Minimum follow-up was 6 months, unless reintervention occurred. Mean follow-up was 277 days (6–923 days). Treatment characteristics were 51 cases with venous-graft anastomosis (VGA) stenosis (79.7%), 13 cases of puncture zone stenosis (20.3%), 14 cases of in SG stenosis (21.9%), 8 cases of pseudoaneurysm treatment (12.5%) (1 treatment area might have had more than 1 characteristic). Thirty-six patients presented with thrombosis (56.2%), and 31 of 64 case were de novo treatment areas (48.4%). Primary outcome measurements were technical success and post-intervention primary patency (PIPP) at 6 months, whereas secondary outcome measurements included factors influencing primary outcome.ResultsTechnical success was 100%. Median PIPP was 336 days, and 73.6% of treatment areas were patent at 6 months. There were no significant differences in terms of PIPP when de novo treatment areas were compared with restenotic areas (519 vs. 320 days, respectively; P = .1); patients who presented with versus those who presented without thrombosis (320 vs. 583 days, respectively; P = .07); puncture zone stenosis or elsewhere (329 vs. 686 days, respectively; P = .52); and VGA stenosis or elsewhere (336 vs. 335 days, respectively; P = .9).ConclusionsUse of the Covera SG for AVG treatment was safe and effective in every type of treatment area presented in this retrospective analysis. 相似文献
8.
9.
10.
Summary A new modification of microvenous anastomosis, which has increased patency rates while simultaneously decreasing the difficulty of the procedure, is presented in this paper. The primary purpose of this study was to compare the classical and the temporary stent techniques of microvenous anastomosis. Because of problems such as mixing and tangling of strings during insertion and tying of the last four sutures while applying the temporary stent technique, we decided to modify the procedure. The silastic tube was removed through an incision (venotomy), distant from the actual suture line. This modified technique and the other above mentioned techniques were carried out on rat femoral veins. The results indicate that this modification has increased patency rates, shortened the time of anastomosis and facilitated the procedure. 相似文献